vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
ALBANY INTERNATIONAL CORP is the larger business by last-quarter revenue ($321.2M vs $205.4M, roughly 1.6× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 4.3%, a 3.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 12.0%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $51.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 1.2%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
AIN vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $205.4M |
| Net Profit | $13.9M | $17.0M |
| Gross Margin | 31.1% | 62.5% |
| Operating Margin | 9.3% | 29.6% |
| Net Margin | 4.3% | 8.3% |
| Revenue YoY | 12.0% | 12.9% |
| Net Profit YoY | -21.5% | 35.3% |
| EPS (diluted) | $0.56 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $205.4M | ||
| Q3 25 | $261.4M | $209.4M | ||
| Q2 25 | $311.4M | $188.0M | ||
| Q1 25 | $288.8M | $177.8M | ||
| Q4 24 | $286.9M | $181.9M | ||
| Q3 24 | $298.4M | $159.3M | ||
| Q2 24 | $332.0M | $145.3M | ||
| Q1 24 | $313.3M | $144.9M |
| Q4 25 | $13.9M | $17.0M | ||
| Q3 25 | $-97.8M | $31.5M | ||
| Q2 25 | $9.2M | $12.0M | ||
| Q1 25 | $17.4M | $2.4M | ||
| Q4 24 | $17.7M | $12.5M | ||
| Q3 24 | $18.0M | $9.3M | ||
| Q2 24 | $24.6M | $19.6M | ||
| Q1 24 | $27.3M | $27.7M |
| Q4 25 | 31.1% | 62.5% | ||
| Q3 25 | -19.1% | 61.7% | ||
| Q2 25 | 31.3% | 57.7% | ||
| Q1 25 | 33.4% | 54.8% | ||
| Q4 24 | 31.5% | 54.0% | ||
| Q3 24 | 30.3% | 60.8% | ||
| Q2 24 | 33.9% | 62.5% | ||
| Q1 24 | 34.7% | 63.1% |
| Q4 25 | 9.3% | 29.6% | ||
| Q3 25 | -44.6% | 29.7% | ||
| Q2 25 | 7.2% | 18.7% | ||
| Q1 25 | 9.8% | 12.2% | ||
| Q4 24 | 8.5% | 20.9% | ||
| Q3 24 | 8.4% | 21.9% | ||
| Q2 24 | 12.9% | 32.7% | ||
| Q1 24 | 12.4% | 34.1% |
| Q4 25 | 4.3% | 8.3% | ||
| Q3 25 | -37.4% | 15.0% | ||
| Q2 25 | 2.9% | 6.4% | ||
| Q1 25 | 6.0% | 1.4% | ||
| Q4 24 | 6.2% | 6.9% | ||
| Q3 24 | 6.0% | 5.9% | ||
| Q2 24 | 7.4% | 13.5% | ||
| Q1 24 | 8.7% | 19.1% |
| Q4 25 | $0.56 | $0.48 | ||
| Q3 25 | $-3.37 | $0.84 | ||
| Q2 25 | $0.31 | $0.34 | ||
| Q1 25 | $0.56 | $0.07 | ||
| Q4 24 | $0.57 | $0.36 | ||
| Q3 24 | $0.57 | $0.27 | ||
| Q2 24 | $0.79 | $0.52 | ||
| Q1 24 | $0.87 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $386.7M |
| Total DebtLower is stronger | $455.7M | — |
| Stockholders' EquityBook value | $726.2M | $301.7M |
| Total Assets | $1.7B | $1.7B |
| Debt / EquityLower = less leverage | 0.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $386.7M | ||
| Q3 25 | $108.3M | $285.9M | ||
| Q2 25 | $106.7M | $222.2M | ||
| Q1 25 | $119.4M | $197.8M | ||
| Q4 24 | $115.3M | $162.8M | ||
| Q3 24 | $127.2M | $120.0M | ||
| Q2 24 | $116.4M | $271.6M | ||
| Q1 24 | $125.4M | $318.0M |
| Q4 25 | $455.7M | — | ||
| Q3 25 | $480.6M | — | ||
| Q2 25 | $444.7M | — | ||
| Q1 25 | $416.4M | — | ||
| Q4 24 | $318.5M | — | ||
| Q3 24 | $362.2M | — | ||
| Q2 24 | $377.1M | — | ||
| Q1 24 | $439.1M | — |
| Q4 25 | $726.2M | $301.7M | ||
| Q3 25 | $739.3M | $274.8M | ||
| Q2 25 | $888.6M | $232.2M | ||
| Q1 25 | $900.0M | $234.4M | ||
| Q4 24 | $943.5M | $228.8M | ||
| Q3 24 | $991.0M | $234.3M | ||
| Q2 24 | $967.5M | $216.6M | ||
| Q1 24 | $967.5M | $222.2M |
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.7B | $1.6B | ||
| Q2 25 | $1.7B | $1.6B | ||
| Q1 25 | $1.7B | $1.6B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.8B | $1.6B | ||
| Q2 24 | $1.8B | $1.1B | ||
| Q1 24 | $1.8B | $1.1B |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.45× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | $123.0M |
| Free Cash FlowOCF − Capex | $51.4M | $122.4M |
| FCF MarginFCF / Revenue | 16.0% | 59.6% |
| Capex IntensityCapex / Revenue | 6.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 5.31× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | $123.0M | ||
| Q3 25 | $43.9M | $78.4M | ||
| Q2 25 | $32.7M | $72.4M | ||
| Q1 25 | $2.1M | $55.4M | ||
| Q4 24 | $78.5M | $84.6M | ||
| Q3 24 | $47.0M | $-9.0M | ||
| Q2 24 | $83.4M | $67.4M | ||
| Q1 24 | $9.6M | $61.9M |
| Q4 25 | $51.4M | $122.4M | ||
| Q3 25 | $25.9M | $78.3M | ||
| Q2 25 | $18.8M | $72.4M | ||
| Q1 25 | $-13.5M | $54.6M | ||
| Q4 24 | $60.2M | $84.1M | ||
| Q3 24 | $31.6M | $-9.2M | ||
| Q2 24 | $63.6M | $67.1M | ||
| Q1 24 | $-17.3M | $61.4M |
| Q4 25 | 16.0% | 59.6% | ||
| Q3 25 | 9.9% | 37.4% | ||
| Q2 25 | 6.0% | 38.5% | ||
| Q1 25 | -4.7% | 30.7% | ||
| Q4 24 | 21.0% | 46.2% | ||
| Q3 24 | 10.6% | -5.8% | ||
| Q2 24 | 19.2% | 46.2% | ||
| Q1 24 | -5.5% | 42.3% |
| Q4 25 | 6.9% | 0.3% | ||
| Q3 25 | 6.9% | 0.1% | ||
| Q2 25 | 4.5% | 0.0% | ||
| Q1 25 | 5.4% | 0.4% | ||
| Q4 24 | 6.4% | 0.3% | ||
| Q3 24 | 5.2% | 0.2% | ||
| Q2 24 | 6.0% | 0.2% | ||
| Q1 24 | 8.6% | 0.4% |
| Q4 25 | 5.31× | 7.25× | ||
| Q3 25 | — | 2.49× | ||
| Q2 25 | 3.56× | 6.05× | ||
| Q1 25 | 0.12× | 22.92× | ||
| Q4 24 | 4.44× | 6.75× | ||
| Q3 24 | 2.61× | -0.96× | ||
| Q2 24 | 3.39× | 3.44× | ||
| Q1 24 | 0.35× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
COLL
Segment breakdown not available.
